nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—RIPK2—leprosy	0.504	1	CbGaD
Dasatinib—FMO3—Dapsone—leprosy	0.148	0.524	CbGbCtD
Dasatinib—CYP1A1—Thalidomide—leprosy	0.031	0.11	CbGbCtD
Dasatinib—CYP3A5—Thalidomide—leprosy	0.0186	0.0659	CbGbCtD
Dasatinib—CYP3A5—Rifampicin—leprosy	0.018	0.0638	CbGbCtD
Dasatinib—CYP3A5—Dapsone—leprosy	0.0149	0.0527	CbGbCtD
Dasatinib—CYP1A2—Thalidomide—leprosy	0.0138	0.0491	CbGbCtD
Dasatinib—CYP1A2—Rifampicin—leprosy	0.0134	0.0475	CbGbCtD
Dasatinib—ABCB1—Rifampicin—leprosy	0.0117	0.0415	CbGbCtD
Dasatinib—CYP3A4—Rifampicin—leprosy	0.00702	0.0249	CbGbCtD
Dasatinib—CYP3A4—Dapsone—leprosy	0.0058	0.0205	CbGbCtD
Dasatinib—Chronic myeloid leukaemia—Thalidomide—leprosy	0.00479	0.0707	CcSEcCtD
Dasatinib—FMO3—sweat—leprosy	0.00471	0.0679	CbGeAlD
Dasatinib—Hypoalbuminaemia—Dapsone—leprosy	0.00404	0.0596	CcSEcCtD
Dasatinib—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00275	0.0406	CcSEcCtD
Dasatinib—PTK6—skin epidermis—leprosy	0.00213	0.0307	CbGeAlD
Dasatinib—Swelling face—Dapsone—leprosy	0.00185	0.0273	CcSEcCtD
Dasatinib—BMPR1B—peripheral nervous system—leprosy	0.00177	0.0255	CbGeAlD
Dasatinib—CSK—Menadione—Thalidomide—leprosy	0.00168	1	CbGdCrCtD
Dasatinib—Tumour lysis syndrome—Thalidomide—leprosy	0.00163	0.024	CcSEcCtD
Dasatinib—ERBB3—peripheral nervous system—leprosy	0.00133	0.0191	CbGeAlD
Dasatinib—EPHB3—nerve—leprosy	0.00125	0.018	CbGeAlD
Dasatinib—MAP3K3—peripheral nervous system—leprosy	0.00112	0.0161	CbGeAlD
Dasatinib—EPHA4—nerve—leprosy	0.00104	0.015	CbGeAlD
Dasatinib—Pericarditis—Thalidomide—leprosy	0.00104	0.0154	CcSEcCtD
Dasatinib—Erythema nodosum—Thalidomide—leprosy	0.00104	0.0154	CcSEcCtD
Dasatinib—Proteinuria—Dapsone—leprosy	0.001	0.0148	CcSEcCtD
Dasatinib—Ascites—Thalidomide—leprosy	0.000993	0.0147	CcSEcCtD
Dasatinib—Protein urine present—Dapsone—leprosy	0.00099	0.0146	CcSEcCtD
Dasatinib—EPHB1—eye—leprosy	0.000965	0.0139	CbGeAlD
Dasatinib—Transient ischaemic attack—Thalidomide—leprosy	0.000895	0.0132	CcSEcCtD
Dasatinib—RIPK2—blood vessel—leprosy	0.000848	0.0122	CbGeAlD
Dasatinib—Skin exfoliation—Dapsone—leprosy	0.000842	0.0124	CcSEcCtD
Dasatinib—TEC—tendon—leprosy	0.000814	0.0117	CbGeAlD
Dasatinib—MYT1—testis—leprosy	0.000793	0.0114	CbGeAlD
Dasatinib—MYT1—nervous system—leprosy	0.000778	0.0112	CbGeAlD
Dasatinib—EPHA8—eye—leprosy	0.00076	0.0109	CbGeAlD
Dasatinib—MAPK14—blood vessel—leprosy	0.000756	0.0109	CbGeAlD
Dasatinib—Febrile neutropenia—Thalidomide—leprosy	0.00075	0.0111	CcSEcCtD
Dasatinib—KIT—skin epidermis—leprosy	0.000742	0.0107	CbGeAlD
Dasatinib—Deep vein thrombosis—Thalidomide—leprosy	0.000742	0.011	CcSEcCtD
Dasatinib—EPHB4—blood vessel—leprosy	0.000717	0.0103	CbGeAlD
Dasatinib—JAK2—blood vessel—leprosy	0.000712	0.0103	CbGeAlD
Dasatinib—BMX—skin of body—leprosy	0.000705	0.0102	CbGeAlD
Dasatinib—Embolism—Thalidomide—leprosy	0.000703	0.0104	CcSEcCtD
Dasatinib—EPHA2—blood vessel—leprosy	0.000703	0.0101	CbGeAlD
Dasatinib—Nail disorder—Thalidomide—leprosy	0.000696	0.0103	CcSEcCtD
Dasatinib—TEC—testis—leprosy	0.000674	0.00972	CbGeAlD
Dasatinib—EPHA3—eye—leprosy	0.000664	0.00957	CbGeAlD
Dasatinib—PTK6—skin of body—leprosy	0.000661	0.00952	CbGeAlD
Dasatinib—EPHB1—tendon—leprosy	0.000639	0.00921	CbGeAlD
Dasatinib—Interstitial lung disease—Thalidomide—leprosy	0.000638	0.00942	CcSEcCtD
Dasatinib—Thrombosis—Thalidomide—leprosy	0.000638	0.00942	CcSEcCtD
Dasatinib—STAT5B—skin of body—leprosy	0.000625	0.00901	CbGeAlD
Dasatinib—SRC—blood vessel—leprosy	0.000609	0.00878	CbGeAlD
Dasatinib—ZAK—eye—leprosy	0.000601	0.00865	CbGeAlD
Dasatinib—Cholestasis—Thalidomide—leprosy	0.000594	0.00878	CcSEcCtD
Dasatinib—Pleural effusion—Thalidomide—leprosy	0.00059	0.0087	CcSEcCtD
Dasatinib—EPHA5—eye—leprosy	0.000588	0.00847	CbGeAlD
Dasatinib—Skin ulcer—Thalidomide—leprosy	0.00058	0.00856	CcSEcCtD
Dasatinib—Rash pustular—Thalidomide—leprosy	0.000566	0.00836	CcSEcCtD
Dasatinib—Muscular weakness—Dapsone—leprosy	0.000565	0.00834	CcSEcCtD
Dasatinib—Petechiae—Thalidomide—leprosy	0.000549	0.0081	CcSEcCtD
Dasatinib—Pancreatitis—Dapsone—leprosy	0.000542	0.00801	CcSEcCtD
Dasatinib—TESK1—eye—leprosy	0.000531	0.00765	CbGeAlD
Dasatinib—EPHB1—testis—leprosy	0.000529	0.00763	CbGeAlD
Dasatinib—EPHB1—nervous system—leprosy	0.000519	0.00748	CbGeAlD
Dasatinib—Proteinuria—Thalidomide—leprosy	0.000514	0.00759	CcSEcCtD
Dasatinib—Protein urine present—Thalidomide—leprosy	0.000507	0.00748	CcSEcCtD
Dasatinib—Photosensitivity reaction—Dapsone—leprosy	0.000505	0.00746	CcSEcCtD
Dasatinib—Musculoskeletal stiffness—Thalidomide—leprosy	0.000503	0.00743	CcSEcCtD
Dasatinib—Skin discolouration—Thalidomide—leprosy	0.0005	0.00738	CcSEcCtD
Dasatinib—KIT—blood vessel—leprosy	0.000497	0.00716	CbGeAlD
Dasatinib—Hypocalcaemia—Thalidomide—leprosy	0.000493	0.00728	CcSEcCtD
Dasatinib—Hyperuricaemia—Thalidomide—leprosy	0.000487	0.00719	CcSEcCtD
Dasatinib—CSK—eye—leprosy	0.000486	0.00701	CbGeAlD
Dasatinib—PDGFRB—blood vessel—leprosy	0.000485	0.00699	CbGeAlD
Dasatinib—Neuropathy peripheral—Dapsone—leprosy	0.000484	0.00714	CcSEcCtD
Dasatinib—Creatinine increased—Thalidomide—leprosy	0.000474	0.007	CcSEcCtD
Dasatinib—Blood uric acid increased—Thalidomide—leprosy	0.00046	0.00679	CcSEcCtD
Dasatinib—SIK2—nervous system—leprosy	0.000459	0.00661	CbGeAlD
Dasatinib—PKMYT1—testis—leprosy	0.000455	0.00656	CbGeAlD
Dasatinib—FRK—testis—leprosy	0.000455	0.00656	CbGeAlD
Dasatinib—Pulmonary embolism—Thalidomide—leprosy	0.000451	0.00667	CcSEcCtD
Dasatinib—RIPK2—eye—leprosy	0.000451	0.0065	CbGeAlD
Dasatinib—PKMYT1—nervous system—leprosy	0.000447	0.00644	CbGeAlD
Dasatinib—Colitis—Thalidomide—leprosy	0.000433	0.0064	CcSEcCtD
Dasatinib—Skin exfoliation—Thalidomide—leprosy	0.000431	0.00636	CcSEcCtD
Dasatinib—SIK3—tendon—leprosy	0.000428	0.00616	CbGeAlD
Dasatinib—EPHB2—nervous system—leprosy	0.000426	0.00615	CbGeAlD
Dasatinib—STK35—skin of body—leprosy	0.000426	0.00614	CbGeAlD
Dasatinib—Neuropathy—Thalidomide—leprosy	0.000424	0.00626	CcSEcCtD
Dasatinib—CSK—skin of body—leprosy	0.000423	0.0061	CbGeAlD
Dasatinib—TXK—testis—leprosy	0.000421	0.00606	CbGeAlD
Dasatinib—SRMS—nervous system—leprosy	0.000417	0.00601	CbGeAlD
Dasatinib—Dry eye—Thalidomide—leprosy	0.000417	0.00616	CcSEcCtD
Dasatinib—EPHA8—testis—leprosy	0.000417	0.006	CbGeAlD
Dasatinib—Tinnitus—Dapsone—leprosy	0.000413	0.0061	CcSEcCtD
Dasatinib—Oesophagitis—Thalidomide—leprosy	0.000413	0.00609	CcSEcCtD
Dasatinib—Rash maculo-papular—Thalidomide—leprosy	0.00041	0.00606	CcSEcCtD
Dasatinib—EPHA8—nervous system—leprosy	0.000409	0.00589	CbGeAlD
Dasatinib—Gynaecomastia—Thalidomide—leprosy	0.000404	0.00596	CcSEcCtD
Dasatinib—Pulmonary oedema—Thalidomide—leprosy	0.000402	0.00593	CcSEcCtD
Dasatinib—ZAK—tendon—leprosy	0.000398	0.00573	CbGeAlD
Dasatinib—STAT5B—testis—leprosy	0.000394	0.00568	CbGeAlD
Dasatinib—RIPK2—skin of body—leprosy	0.000393	0.00566	CbGeAlD
Dasatinib—Sepsis—Thalidomide—leprosy	0.000392	0.00578	CcSEcCtD
Dasatinib—FMO3—eye—leprosy	0.000387	0.00558	CbGeAlD
Dasatinib—CYP1A1—skin epidermis—leprosy	0.000387	0.00558	CbGeAlD
Dasatinib—STAT5B—nervous system—leprosy	0.000387	0.00557	CbGeAlD
Dasatinib—Erythema—Dapsone—leprosy	0.000386	0.00569	CcSEcCtD
Dasatinib—SIK1—skin of body—leprosy	0.000383	0.00553	CbGeAlD
Dasatinib—BTK—tendon—leprosy	0.000379	0.00547	CbGeAlD
Dasatinib—Thrombophlebitis—Thalidomide—leprosy	0.000379	0.00559	CcSEcCtD
Dasatinib—ERBB3—skin of body—leprosy	0.000376	0.00542	CbGeAlD
Dasatinib—Photosensitivity—Thalidomide—leprosy	0.000373	0.00551	CcSEcCtD
Dasatinib—Eczema—Thalidomide—leprosy	0.000365	0.00538	CcSEcCtD
Dasatinib—EPHA3—testis—leprosy	0.000364	0.00525	CbGeAlD
Dasatinib—Vision blurred—Dapsone—leprosy	0.000363	0.00536	CcSEcCtD
Dasatinib—Cardiac failure congestive—Thalidomide—leprosy	0.000361	0.00534	CcSEcCtD
Dasatinib—EPHA3—nervous system—leprosy	0.000357	0.00515	CbGeAlD
Dasatinib—SIK3—testis—leprosy	0.000354	0.0051	CbGeAlD
Dasatinib—Libido decreased—Thalidomide—leprosy	0.000353	0.00522	CcSEcCtD
Dasatinib—TESK1—tendon—leprosy	0.000352	0.00507	CbGeAlD
Dasatinib—MAPK14—skin of body—leprosy	0.00035	0.00504	CbGeAlD
Dasatinib—Amnesia—Thalidomide—leprosy	0.000349	0.00515	CcSEcCtD
Dasatinib—SIK3—nervous system—leprosy	0.000348	0.00501	CbGeAlD
Dasatinib—Vertigo—Dapsone—leprosy	0.000346	0.00511	CcSEcCtD
Dasatinib—STK36—tendon—leprosy	0.000346	0.00499	CbGeAlD
Dasatinib—Atrial fibrillation—Thalidomide—leprosy	0.000346	0.00511	CcSEcCtD
Dasatinib—Visual disturbance—Thalidomide—leprosy	0.000346	0.00511	CcSEcCtD
Dasatinib—YES1—eye—leprosy	0.000337	0.00486	CbGeAlD
Dasatinib—Cough—Dapsone—leprosy	0.000336	0.00497	CcSEcCtD
Dasatinib—Cardiac failure—Thalidomide—leprosy	0.000336	0.00496	CcSEcCtD
Dasatinib—Cerebrovascular accident—Thalidomide—leprosy	0.000334	0.00494	CcSEcCtD
Dasatinib—JAK2—skin of body—leprosy	0.000329	0.00475	CbGeAlD
Dasatinib—ZAK—testis—leprosy	0.000329	0.00475	CbGeAlD
Dasatinib—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000328	0.00484	CcSEcCtD
Dasatinib—Disturbance in sexual arousal—Thalidomide—leprosy	0.000325	0.0048	CcSEcCtD
Dasatinib—FYN—skin of body—leprosy	0.000325	0.00468	CbGeAlD
Dasatinib—SRC—eye—leprosy	0.000324	0.00467	CbGeAlD
Dasatinib—STK35—tendon—leprosy	0.000324	0.00467	CbGeAlD
Dasatinib—ZAK—nervous system—leprosy	0.000323	0.00466	CbGeAlD
Dasatinib—Affect lability—Thalidomide—leprosy	0.000323	0.00476	CcSEcCtD
Dasatinib—CSK—tendon—leprosy	0.000322	0.00464	CbGeAlD
Dasatinib—HCK—tendon—leprosy	0.000318	0.00458	CbGeAlD
Dasatinib—MAP3K3—skin of body—leprosy	0.000318	0.00458	CbGeAlD
Dasatinib—Face oedema—Thalidomide—leprosy	0.000316	0.00467	CcSEcCtD
Dasatinib—EPHA5—nervous system—leprosy	0.000316	0.00456	CbGeAlD
Dasatinib—ABL2—tendon—leprosy	0.000316	0.00455	CbGeAlD
Dasatinib—BMPR1B—testis—leprosy	0.000316	0.00455	CbGeAlD
Dasatinib—MAP3K19—testis—leprosy	0.000316	0.00455	CbGeAlD
Dasatinib—LYN—nervous system—leprosy	0.000315	0.00453	CbGeAlD
Dasatinib—BTK—testis—leprosy	0.000314	0.00453	CbGeAlD
Dasatinib—MAP3K19—nervous system—leprosy	0.00031	0.00447	CbGeAlD
Dasatinib—BMPR1B—nervous system—leprosy	0.00031	0.00447	CbGeAlD
Dasatinib—TNK2—testis—leprosy	0.00031	0.00446	CbGeAlD
Dasatinib—Tachycardia—Dapsone—leprosy	0.000307	0.00453	CcSEcCtD
Dasatinib—Blood creatinine increased—Thalidomide—leprosy	0.000307	0.00453	CcSEcCtD
Dasatinib—TNK2—nervous system—leprosy	0.000304	0.00438	CbGeAlD
Dasatinib—EPHB6—skin of body—leprosy	0.000303	0.00437	CbGeAlD
Dasatinib—Dry skin—Thalidomide—leprosy	0.0003	0.00444	CcSEcCtD
Dasatinib—RIPK2—tendon—leprosy	0.000299	0.00431	CbGeAlD
Dasatinib—Hypokalaemia—Thalidomide—leprosy	0.000298	0.0044	CcSEcCtD
Dasatinib—Breast disorder—Thalidomide—leprosy	0.000296	0.00437	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000295	0.00436	CcSEcCtD
Dasatinib—SIK1—tendon—leprosy	0.000292	0.00421	CbGeAlD
Dasatinib—CSF1R—eye—leprosy	0.000291	0.0042	CbGeAlD
Dasatinib—TESK1—testis—leprosy	0.000291	0.00419	CbGeAlD
Dasatinib—Muscular weakness—Thalidomide—leprosy	0.000289	0.00427	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000289	0.00427	CcSEcCtD
Dasatinib—EPHA4—tendon—leprosy	0.000289	0.00416	CbGeAlD
Dasatinib—STK36—testis—leprosy	0.000286	0.00413	CbGeAlD
Dasatinib—EPHB3—testis—leprosy	0.000286	0.00413	CbGeAlD
Dasatinib—TESK1—nervous system—leprosy	0.000286	0.00412	CbGeAlD
Dasatinib—Abdominal distension—Thalidomide—leprosy	0.000285	0.00421	CcSEcCtD
Dasatinib—Insomnia—Dapsone—leprosy	0.000285	0.0042	CcSEcCtD
Dasatinib—Dysphagia—Thalidomide—leprosy	0.000283	0.00418	CcSEcCtD
Dasatinib—SRC—skin of body—leprosy	0.000282	0.00407	CbGeAlD
Dasatinib—STK36—nervous system—leprosy	0.000281	0.00405	CbGeAlD
Dasatinib—EPHB3—nervous system—leprosy	0.000281	0.00405	CbGeAlD
Dasatinib—Bronchospasm—Thalidomide—leprosy	0.000279	0.00411	CcSEcCtD
Dasatinib—Pancreatitis—Thalidomide—leprosy	0.000278	0.0041	CcSEcCtD
Dasatinib—LIMK2—testis—leprosy	0.000277	0.00399	CbGeAlD
Dasatinib—Angina pectoris—Thalidomide—leprosy	0.000276	0.00407	CcSEcCtD
Dasatinib—LIMK2—nervous system—leprosy	0.000272	0.00392	CbGeAlD
Dasatinib—Pancytopenia—Thalidomide—leprosy	0.000269	0.00397	CcSEcCtD
Dasatinib—STK35—testis—leprosy	0.000268	0.00387	CbGeAlD
Dasatinib—CSK—testis—leprosy	0.000267	0.00384	CbGeAlD
Dasatinib—MAPK14—tendon—leprosy	0.000266	0.00384	CbGeAlD
Dasatinib—FGR—tendon—leprosy	0.000265	0.00382	CbGeAlD
Dasatinib—Neutropenia—Thalidomide—leprosy	0.000265	0.00391	CcSEcCtD
Dasatinib—STK35—nervous system—leprosy	0.000263	0.0038	CbGeAlD
Dasatinib—HCK—testis—leprosy	0.000263	0.00379	CbGeAlD
Dasatinib—Upper respiratory tract infection—Thalidomide—leprosy	0.000263	0.00389	CcSEcCtD
Dasatinib—CSK—nervous system—leprosy	0.000262	0.00377	CbGeAlD
Dasatinib—Pollakiuria—Thalidomide—leprosy	0.000262	0.00386	CcSEcCtD
Dasatinib—ABL2—testis—leprosy	0.000262	0.00377	CbGeAlD
Dasatinib—Photosensitivity reaction—Thalidomide—leprosy	0.000259	0.00382	CcSEcCtD
Dasatinib—HCK—nervous system—leprosy	0.000258	0.00372	CbGeAlD
Dasatinib—PDGFRB—eye—leprosy	0.000258	0.00372	CbGeAlD
Dasatinib—Weight increased—Thalidomide—leprosy	0.000258	0.00381	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dapsone—leprosy	0.000257	0.0038	CcSEcCtD
Dasatinib—Weight decreased—Thalidomide—leprosy	0.000256	0.00378	CcSEcCtD
Dasatinib—Pneumonia—Thalidomide—leprosy	0.000254	0.00375	CcSEcCtD
Dasatinib—CSF1R—skin of body—leprosy	0.000253	0.00365	CbGeAlD
Dasatinib—EPHB4—tendon—leprosy	0.000253	0.00364	CbGeAlD
Dasatinib—Infestation—Thalidomide—leprosy	0.000253	0.00373	CcSEcCtD
Dasatinib—Infestation NOS—Thalidomide—leprosy	0.000253	0.00373	CcSEcCtD
Dasatinib—JAK2—tendon—leprosy	0.000251	0.00361	CbGeAlD
Dasatinib—Acute coronary syndrome—Thalidomide—leprosy	0.000249	0.00368	CcSEcCtD
Dasatinib—Abdominal pain—Dapsone—leprosy	0.000249	0.00367	CcSEcCtD
Dasatinib—Body temperature increased—Dapsone—leprosy	0.000249	0.00367	CcSEcCtD
Dasatinib—Renal failure—Thalidomide—leprosy	0.000248	0.00367	CcSEcCtD
Dasatinib—EPHA2—tendon—leprosy	0.000248	0.00357	CbGeAlD
Dasatinib—Neuropathy peripheral—Thalidomide—leprosy	0.000248	0.00365	CcSEcCtD
Dasatinib—Myocardial infarction—Thalidomide—leprosy	0.000248	0.00365	CcSEcCtD
Dasatinib—RIPK2—testis—leprosy	0.000248	0.00357	CbGeAlD
Dasatinib—FYN—tendon—leprosy	0.000247	0.00356	CbGeAlD
Dasatinib—Stomatitis—Thalidomide—leprosy	0.000246	0.00363	CcSEcCtD
Dasatinib—Conjunctivitis—Thalidomide—leprosy	0.000245	0.00362	CcSEcCtD
Dasatinib—MAP3K3—tendon—leprosy	0.000242	0.00348	CbGeAlD
Dasatinib—MAP4K5—tendon—leprosy	0.000242	0.00348	CbGeAlD
Dasatinib—SIK1—testis—leprosy	0.000242	0.00348	CbGeAlD
Dasatinib—Haematuria—Thalidomide—leprosy	0.000241	0.00356	CcSEcCtD
Dasatinib—EPHA4—testis—leprosy	0.000239	0.00345	CbGeAlD
Dasatinib—Epistaxis—Thalidomide—leprosy	0.000238	0.00352	CcSEcCtD
Dasatinib—SIK1—nervous system—leprosy	0.000237	0.00342	CbGeAlD
Dasatinib—ERBB3—testis—leprosy	0.000237	0.00341	CbGeAlD
Dasatinib—EPHA4—nervous system—leprosy	0.000235	0.00338	CbGeAlD
Dasatinib—MAP3K2—testis—leprosy	0.000235	0.00338	CbGeAlD
Dasatinib—ERBB3—nervous system—leprosy	0.000233	0.00335	CbGeAlD
Dasatinib—EPHB6—tendon—leprosy	0.000231	0.00333	CbGeAlD
Dasatinib—MAP3K2—nervous system—leprosy	0.00023	0.00332	CbGeAlD
Dasatinib—ABL1—eye—leprosy	0.00023	0.00332	CbGeAlD
Dasatinib—KIT—skin of body—leprosy	0.00023	0.00331	CbGeAlD
Dasatinib—Hepatitis—Thalidomide—leprosy	0.000227	0.00335	CcSEcCtD
Dasatinib—PDGFRB—skin of body—leprosy	0.000225	0.00324	CbGeAlD
Dasatinib—Urinary tract disorder—Thalidomide—leprosy	0.000224	0.00331	CcSEcCtD
Dasatinib—Oedema peripheral—Thalidomide—leprosy	0.000223	0.0033	CcSEcCtD
Dasatinib—YES1—tendon—leprosy	0.000223	0.00322	CbGeAlD
Dasatinib—Urethral disorder—Thalidomide—leprosy	0.000222	0.00328	CcSEcCtD
Dasatinib—MAPK14—testis—leprosy	0.000221	0.00318	CbGeAlD
Dasatinib—LCK—testis—leprosy	0.00022	0.00317	CbGeAlD
Dasatinib—FGR—testis—leprosy	0.00022	0.00317	CbGeAlD
Dasatinib—PDGFRA—tendon—leprosy	0.000219	0.00316	CbGeAlD
Dasatinib—Visual impairment—Thalidomide—leprosy	0.000218	0.00323	CcSEcCtD
Dasatinib—MAPK14—nervous system—leprosy	0.000217	0.00312	CbGeAlD
Dasatinib—FGR—nervous system—leprosy	0.000216	0.00311	CbGeAlD
Dasatinib—Erythema multiforme—Thalidomide—leprosy	0.000214	0.00316	CcSEcCtD
Dasatinib—FMO3—testis—leprosy	0.000212	0.00306	CbGeAlD
Dasatinib—Eye disorder—Thalidomide—leprosy	0.000212	0.00313	CcSEcCtD
Dasatinib—Tinnitus—Thalidomide—leprosy	0.000211	0.00312	CcSEcCtD
Dasatinib—Cardiac disorder—Thalidomide—leprosy	0.00021	0.00311	CcSEcCtD
Dasatinib—EPHB4—testis—leprosy	0.000209	0.00301	CbGeAlD
Dasatinib—FMO3—nervous system—leprosy	0.000208	0.003	CbGeAlD
Dasatinib—JAK2—testis—leprosy	0.000208	0.00299	CbGeAlD
Dasatinib—Angiopathy—Thalidomide—leprosy	0.000206	0.00304	CcSEcCtD
Dasatinib—EPHA2—testis—leprosy	0.000205	0.00296	CbGeAlD
Dasatinib—FYN—testis—leprosy	0.000205	0.00295	CbGeAlD
Dasatinib—Immune system disorder—Thalidomide—leprosy	0.000205	0.00302	CcSEcCtD
Dasatinib—Mediastinal disorder—Thalidomide—leprosy	0.000204	0.00302	CcSEcCtD
Dasatinib—JAK2—nervous system—leprosy	0.000204	0.00294	CbGeAlD
Dasatinib—Chills—Thalidomide—leprosy	0.000203	0.003	CcSEcCtD
Dasatinib—Arrhythmia—Thalidomide—leprosy	0.000203	0.00299	CcSEcCtD
Dasatinib—EPHA2—nervous system—leprosy	0.000201	0.0029	CbGeAlD
Dasatinib—FYN—nervous system—leprosy	0.000201	0.0029	CbGeAlD
Dasatinib—Alopecia—Thalidomide—leprosy	0.0002	0.00296	CcSEcCtD
Dasatinib—ABL1—skin of body—leprosy	0.0002	0.00289	CbGeAlD
Dasatinib—MAP4K5—testis—leprosy	0.0002	0.00288	CbGeAlD
Dasatinib—MAP3K3—testis—leprosy	0.0002	0.00288	CbGeAlD
Dasatinib—Vomiting—Dapsone—leprosy	0.0002	0.00295	CcSEcCtD
Dasatinib—Mental disorder—Thalidomide—leprosy	0.000199	0.00293	CcSEcCtD
Dasatinib—MAP2K5—tendon—leprosy	0.000198	0.00285	CbGeAlD
Dasatinib—Malnutrition—Thalidomide—leprosy	0.000197	0.00291	CcSEcCtD
Dasatinib—Headache—Dapsone—leprosy	0.000197	0.00291	CcSEcCtD
Dasatinib—MAP4K5—nervous system—leprosy	0.000196	0.00283	CbGeAlD
Dasatinib—MAP3K3—nervous system—leprosy	0.000196	0.00283	CbGeAlD
Dasatinib—CYP1B1—eye—leprosy	0.000195	0.00281	CbGeAlD
Dasatinib—Dysgeusia—Thalidomide—leprosy	0.000193	0.00285	CcSEcCtD
Dasatinib—CSF1R—tendon—leprosy	0.000193	0.00278	CbGeAlD
Dasatinib—EPHB6—testis—leprosy	0.000191	0.00276	CbGeAlD
Dasatinib—Muscle spasms—Thalidomide—leprosy	0.00019	0.0028	CcSEcCtD
Dasatinib—EPHB6—nervous system—leprosy	0.000188	0.00271	CbGeAlD
Dasatinib—Nausea—Dapsone—leprosy	0.000187	0.00276	CcSEcCtD
Dasatinib—Vision blurred—Thalidomide—leprosy	0.000186	0.00275	CcSEcCtD
Dasatinib—Tremor—Thalidomide—leprosy	0.000185	0.00273	CcSEcCtD
Dasatinib—YES1—testis—leprosy	0.000185	0.00266	CbGeAlD
Dasatinib—Ill-defined disorder—Thalidomide—leprosy	0.000183	0.0027	CcSEcCtD
Dasatinib—Anaemia—Thalidomide—leprosy	0.000182	0.00269	CcSEcCtD
Dasatinib—YES1—nervous system—leprosy	0.000181	0.00261	CbGeAlD
Dasatinib—PDGFRA—testis—leprosy	0.000181	0.00261	CbGeAlD
Dasatinib—Malaise—Thalidomide—leprosy	0.000178	0.00263	CcSEcCtD
Dasatinib—PDGFRA—nervous system—leprosy	0.000178	0.00256	CbGeAlD
Dasatinib—SRC—testis—leprosy	0.000178	0.00256	CbGeAlD
Dasatinib—Vertigo—Thalidomide—leprosy	0.000177	0.00262	CcSEcCtD
Dasatinib—Syncope—Thalidomide—leprosy	0.000177	0.00261	CcSEcCtD
Dasatinib—SRC—nervous system—leprosy	0.000175	0.00252	CbGeAlD
Dasatinib—Palpitations—Thalidomide—leprosy	0.000174	0.00258	CcSEcCtD
Dasatinib—Loss of consciousness—Thalidomide—leprosy	0.000173	0.00256	CcSEcCtD
Dasatinib—Cough—Thalidomide—leprosy	0.000172	0.00254	CcSEcCtD
Dasatinib—PDGFRB—tendon—leprosy	0.000171	0.00246	CbGeAlD
Dasatinib—Convulsion—Thalidomide—leprosy	0.000171	0.00252	CcSEcCtD
Dasatinib—Hypertension—Thalidomide—leprosy	0.00017	0.00252	CcSEcCtD
Dasatinib—CYP1B1—skin of body—leprosy	0.00017	0.00244	CbGeAlD
Dasatinib—Arthralgia—Thalidomide—leprosy	0.000168	0.00248	CcSEcCtD
Dasatinib—Chest pain—Thalidomide—leprosy	0.000168	0.00248	CcSEcCtD
Dasatinib—Myalgia—Thalidomide—leprosy	0.000168	0.00248	CcSEcCtD
Dasatinib—Anxiety—Thalidomide—leprosy	0.000167	0.00247	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000167	0.00246	CcSEcCtD
Dasatinib—Discomfort—Thalidomide—leprosy	0.000166	0.00245	CcSEcCtD
Dasatinib—MAP2K5—testis—leprosy	0.000164	0.00236	CbGeAlD
Dasatinib—Confusional state—Thalidomide—leprosy	0.000162	0.0024	CcSEcCtD
Dasatinib—Oedema—Thalidomide—leprosy	0.000161	0.00238	CcSEcCtD
Dasatinib—MAP2K5—nervous system—leprosy	0.000161	0.00231	CbGeAlD
Dasatinib—Infection—Thalidomide—leprosy	0.00016	0.00236	CcSEcCtD
Dasatinib—CSF1R—testis—leprosy	0.00016	0.0023	CbGeAlD
Dasatinib—Shock—Thalidomide—leprosy	0.000158	0.00234	CcSEcCtD
Dasatinib—Nervous system disorder—Thalidomide—leprosy	0.000158	0.00233	CcSEcCtD
Dasatinib—Thrombocytopenia—Thalidomide—leprosy	0.000158	0.00233	CcSEcCtD
Dasatinib—Tachycardia—Thalidomide—leprosy	0.000157	0.00232	CcSEcCtD
Dasatinib—CSF1R—nervous system—leprosy	0.000157	0.00226	CbGeAlD
Dasatinib—Skin disorder—Thalidomide—leprosy	0.000156	0.00231	CcSEcCtD
Dasatinib—Hyperhidrosis—Thalidomide—leprosy	0.000156	0.0023	CcSEcCtD
Dasatinib—Anorexia—Thalidomide—leprosy	0.000154	0.00227	CcSEcCtD
Dasatinib—ABL1—tendon—leprosy	0.000152	0.0022	CbGeAlD
Dasatinib—Hypotension—Thalidomide—leprosy	0.000151	0.00222	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000147	0.00217	CcSEcCtD
Dasatinib—Insomnia—Thalidomide—leprosy	0.000146	0.00215	CcSEcCtD
Dasatinib—KIT—testis—leprosy	0.000145	0.00209	CbGeAlD
Dasatinib—Dyspnoea—Thalidomide—leprosy	0.000144	0.00212	CcSEcCtD
Dasatinib—Somnolence—Thalidomide—leprosy	0.000143	0.00211	CcSEcCtD
Dasatinib—KIT—nervous system—leprosy	0.000142	0.00205	CbGeAlD
Dasatinib—Dyspepsia—Thalidomide—leprosy	0.000142	0.00209	CcSEcCtD
Dasatinib—PDGFRB—testis—leprosy	0.000142	0.00204	CbGeAlD
Dasatinib—Decreased appetite—Thalidomide—leprosy	0.00014	0.00207	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Thalidomide—leprosy	0.000139	0.00205	CcSEcCtD
Dasatinib—PDGFRB—nervous system—leprosy	0.000139	0.002	CbGeAlD
Dasatinib—Fatigue—Thalidomide—leprosy	0.000139	0.00205	CcSEcCtD
Dasatinib—Constipation—Thalidomide—leprosy	0.000138	0.00203	CcSEcCtD
Dasatinib—Pain—Thalidomide—leprosy	0.000138	0.00203	CcSEcCtD
Dasatinib—ABCB1—blood vessel—leprosy	0.000134	0.00194	CbGeAlD
Dasatinib—Feeling abnormal—Thalidomide—leprosy	0.000133	0.00196	CcSEcCtD
Dasatinib—Gastrointestinal pain—Thalidomide—leprosy	0.000132	0.00194	CcSEcCtD
Dasatinib—CYP1B1—tendon—leprosy	0.000129	0.00186	CbGeAlD
Dasatinib—Urticaria—Thalidomide—leprosy	0.000128	0.00189	CcSEcCtD
Dasatinib—Body temperature increased—Thalidomide—leprosy	0.000127	0.00188	CcSEcCtD
Dasatinib—Abdominal pain—Thalidomide—leprosy	0.000127	0.00188	CcSEcCtD
Dasatinib—ABL1—testis—leprosy	0.000126	0.00182	CbGeAlD
Dasatinib—ABL1—nervous system—leprosy	0.000124	0.00178	CbGeAlD
Dasatinib—CYP1A1—skin of body—leprosy	0.00012	0.00173	CbGeAlD
Dasatinib—Hypersensitivity—Thalidomide—leprosy	0.000119	0.00175	CcSEcCtD
Dasatinib—Asthenia—Thalidomide—leprosy	0.000116	0.00171	CcSEcCtD
Dasatinib—Pruritus—Thalidomide—leprosy	0.000114	0.00168	CcSEcCtD
Dasatinib—Diarrhoea—Thalidomide—leprosy	0.00011	0.00163	CcSEcCtD
Dasatinib—CYP1B1—testis—leprosy	0.000107	0.00154	CbGeAlD
Dasatinib—Dizziness—Thalidomide—leprosy	0.000107	0.00157	CcSEcCtD
Dasatinib—CYP1B1—nervous system—leprosy	0.000105	0.00151	CbGeAlD
Dasatinib—Vomiting—Thalidomide—leprosy	0.000102	0.00151	CcSEcCtD
Dasatinib—Rash—Thalidomide—leprosy	0.000102	0.0015	CcSEcCtD
Dasatinib—Dermatitis—Thalidomide—leprosy	0.000101	0.0015	CcSEcCtD
Dasatinib—Headache—Thalidomide—leprosy	0.000101	0.00149	CcSEcCtD
Dasatinib—Nausea—Thalidomide—leprosy	9.57e-05	0.00141	CcSEcCtD
Dasatinib—ABCG2—testis—leprosy	7.96e-05	0.00115	CbGeAlD
Dasatinib—CYP1A1—nervous system—leprosy	7.41e-05	0.00107	CbGeAlD
Dasatinib—CYP3A4—nervous system—leprosy	5.44e-05	0.000784	CbGeAlD
Dasatinib—ABCB1—testis—leprosy	3.92e-05	0.000565	CbGeAlD
Dasatinib—ABCB1—nervous system—leprosy	3.85e-05	0.000555	CbGeAlD
Dasatinib—BTK—Immune System—HLA-DRB1—leprosy	1.84e-05	0.000247	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—SDHD—leprosy	1.83e-05	0.000245	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—CD8A—leprosy	1.83e-05	0.000245	CbGpPWpGaD
Dasatinib—LYN—Cytokine Signaling in Immune system—IL2—leprosy	1.82e-05	0.000244	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—HLA-DRB1—leprosy	1.81e-05	0.000243	CbGpPWpGaD
Dasatinib—YES1—Immune System—NOD2—leprosy	1.81e-05	0.000242	CbGpPWpGaD
Dasatinib—LCK—Platelet activation, signaling and aggregation—IL2—leprosy	1.81e-05	0.000242	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.8e-05	0.000241	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—IL2—leprosy	1.8e-05	0.000241	CbGpPWpGaD
Dasatinib—KIT—Immune System—RIPK2—leprosy	1.78e-05	0.000239	CbGpPWpGaD
Dasatinib—KIT—Immune System—TLR2—leprosy	1.78e-05	0.000239	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—RIPK2—leprosy	1.78e-05	0.000238	CbGpPWpGaD
Dasatinib—BLK—Adaptive Immune System—CD4—leprosy	1.78e-05	0.000238	CbGpPWpGaD
Dasatinib—JAK2—Disease—SLC11A1—leprosy	1.76e-05	0.000236	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CD40LG—leprosy	1.74e-05	0.000233	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CD8A—leprosy	1.72e-05	0.000231	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—HLA-DRB1—leprosy	1.72e-05	0.00023	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.71e-05	0.000229	CbGpPWpGaD
Dasatinib—JAK2—Cytokine Signaling in Immune system—IL2—leprosy	1.71e-05	0.000229	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—CD4—leprosy	1.7e-05	0.000228	CbGpPWpGaD
Dasatinib—HCK—Immune System—HLA-DRB1—leprosy	1.69e-05	0.000226	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—RIPK2—leprosy	1.69e-05	0.000226	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—TLR2—leprosy	1.69e-05	0.000226	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—IFNG—leprosy	1.68e-05	0.000225	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—NOD2—leprosy	1.68e-05	0.000225	CbGpPWpGaD
Dasatinib—SRC—Immune System—CYLD—leprosy	1.68e-05	0.000224	CbGpPWpGaD
Dasatinib—LCK—Immune System—PARK2—leprosy	1.67e-05	0.000224	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—SDHD—leprosy	1.67e-05	0.000223	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—CD4—leprosy	1.63e-05	0.000218	CbGpPWpGaD
Dasatinib—KIT—Immune System—NOD2—leprosy	1.62e-05	0.000216	CbGpPWpGaD
Dasatinib—CSK—Immune System—IFNG—leprosy	1.61e-05	0.000215	CbGpPWpGaD
Dasatinib—SRC—Platelet activation, signaling and aggregation—IL2—leprosy	1.6e-05	0.000214	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HLA-DRB1—leprosy	1.59e-05	0.000213	CbGpPWpGaD
Dasatinib—ABCB1—Allograft Rejection—TNF—leprosy	1.57e-05	0.00021	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—IFNG—leprosy	1.56e-05	0.000208	CbGpPWpGaD
Dasatinib—CSK—Immune System—CD4—leprosy	1.55e-05	0.000208	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HLA-DRB1—leprosy	1.55e-05	0.000207	CbGpPWpGaD
Dasatinib—LCK—Disease—SLC11A1—leprosy	1.54e-05	0.000207	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CD40LG—leprosy	1.54e-05	0.000206	CbGpPWpGaD
Dasatinib—BLK—Immune System—HLA-DRB1—leprosy	1.53e-05	0.000205	CbGpPWpGaD
Dasatinib—YES1—Immune System—CD40LG—leprosy	1.53e-05	0.000205	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—NOD2—leprosy	1.53e-05	0.000205	CbGpPWpGaD
Dasatinib—FGR—Immune System—HLA-DRB1—leprosy	1.53e-05	0.000204	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—RIPK2—leprosy	1.52e-05	0.000204	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—IL2—leprosy	1.52e-05	0.000204	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CD8A—leprosy	1.52e-05	0.000204	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—RIPK2—leprosy	1.52e-05	0.000204	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—TLR2—leprosy	1.52e-05	0.000204	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HLA-DRB1—leprosy	1.51e-05	0.000203	CbGpPWpGaD
Dasatinib—YES1—Immune System—CD8A—leprosy	1.51e-05	0.000203	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—CD4—leprosy	1.5e-05	0.000201	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—IL2—leprosy	1.5e-05	0.0002	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—CD4—leprosy	1.49e-05	0.0002	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HLA-DRB1—leprosy	1.49e-05	0.0002	CbGpPWpGaD
Dasatinib—LYN—Immune System—RIPK2—leprosy	1.49e-05	0.000199	CbGpPWpGaD
Dasatinib—LYN—Immune System—TLR2—leprosy	1.49e-05	0.000199	CbGpPWpGaD
Dasatinib—SRC—Immune System—PARK2—leprosy	1.48e-05	0.000198	CbGpPWpGaD
Dasatinib—ABL1—Immune System—RIPK2—leprosy	1.48e-05	0.000198	CbGpPWpGaD
Dasatinib—ABL1—Immune System—TLR2—leprosy	1.48e-05	0.000198	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—RIPK2—leprosy	1.47e-05	0.000197	CbGpPWpGaD
Dasatinib—FYN—Immune System—RIPK2—leprosy	1.46e-05	0.000196	CbGpPWpGaD
Dasatinib—FYN—Immune System—TLR2—leprosy	1.46e-05	0.000196	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.45e-05	0.000194	CbGpPWpGaD
Dasatinib—CSK—Disease—CD4—leprosy	1.43e-05	0.000192	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—CD4—leprosy	1.43e-05	0.000192	CbGpPWpGaD
Dasatinib—CSK—Immune System—IL2—leprosy	1.43e-05	0.000191	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—RIPK2—leprosy	1.41e-05	0.000189	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—TLR2—leprosy	1.41e-05	0.000189	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HLA-DRB1—leprosy	1.4e-05	0.000188	CbGpPWpGaD
Dasatinib—JAK2—Immune System—RIPK2—leprosy	1.39e-05	0.000186	CbGpPWpGaD
Dasatinib—JAK2—Immune System—TLR2—leprosy	1.39e-05	0.000186	CbGpPWpGaD
Dasatinib—STAT5B—Disease—CD4—leprosy	1.39e-05	0.000186	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—IL2—leprosy	1.38e-05	0.000185	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—IFNG—leprosy	1.38e-05	0.000185	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NOD2—leprosy	1.38e-05	0.000185	CbGpPWpGaD
Dasatinib—SRC—Disease—SLC11A1—leprosy	1.37e-05	0.000183	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD40LG—leprosy	1.37e-05	0.000183	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD40LG—leprosy	1.36e-05	0.000183	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD8A—leprosy	1.35e-05	0.000181	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD8A—leprosy	1.35e-05	0.000181	CbGpPWpGaD
Dasatinib—LYN—Immune System—NOD2—leprosy	1.35e-05	0.000181	CbGpPWpGaD
Dasatinib—BTK—Immune System—IFNG—leprosy	1.34e-05	0.00018	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NOD2—leprosy	1.34e-05	0.00018	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—CD4—leprosy	1.33e-05	0.000179	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—CD4—leprosy	1.33e-05	0.000178	CbGpPWpGaD
Dasatinib—FYN—Immune System—NOD2—leprosy	1.33e-05	0.000178	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—IL2—leprosy	1.31e-05	0.000176	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.31e-05	0.000175	CbGpPWpGaD
Dasatinib—BTK—Immune System—CD4—leprosy	1.3e-05	0.000174	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD40LG—leprosy	1.29e-05	0.000173	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—RIPK2—leprosy	1.29e-05	0.000173	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—CD4—leprosy	1.28e-05	0.000171	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NOD2—leprosy	1.28e-05	0.000171	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD8A—leprosy	1.28e-05	0.000171	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NOD2—leprosy	1.26e-05	0.000169	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—CD4—leprosy	1.26e-05	0.000169	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-DRB1—leprosy	1.24e-05	0.000166	CbGpPWpGaD
Dasatinib—HCK—Immune System—IFNG—leprosy	1.23e-05	0.000165	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-DRB1—leprosy	1.23e-05	0.000165	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—IL2—leprosy	1.23e-05	0.000164	CbGpPWpGaD
Dasatinib—LCK—Immune System—RIPK2—leprosy	1.22e-05	0.000163	CbGpPWpGaD
Dasatinib—LCK—Immune System—TLR2—leprosy	1.22e-05	0.000163	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—CD4—leprosy	1.21e-05	0.000162	CbGpPWpGaD
Dasatinib—BTK—Immune System—IL2—leprosy	1.19e-05	0.00016	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SDHD—leprosy	1.19e-05	0.00016	CbGpPWpGaD
Dasatinib—HCK—Immune System—CD4—leprosy	1.19e-05	0.00016	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD40LG—leprosy	1.16e-05	0.000156	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—IFNG—leprosy	1.16e-05	0.000156	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RIPK2—leprosy	1.15e-05	0.000154	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD8A—leprosy	1.15e-05	0.000154	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD40LG—leprosy	1.14e-05	0.000153	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—IL2—leprosy	1.14e-05	0.000152	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—CD4—leprosy	1.14e-05	0.000152	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD40LG—leprosy	1.13e-05	0.000152	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TNF—leprosy	1.13e-05	0.000152	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—IL2—leprosy	1.13e-05	0.000151	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SDHD—leprosy	1.13e-05	0.000151	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD8A—leprosy	1.13e-05	0.000151	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD40LG—leprosy	1.12e-05	0.00015	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD8A—leprosy	1.12e-05	0.00015	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—CD4—leprosy	1.12e-05	0.00015	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—IL2—leprosy	1.12e-05	0.00015	CbGpPWpGaD
Dasatinib—BLK—Immune System—IFNG—leprosy	1.12e-05	0.00015	CbGpPWpGaD
Dasatinib—FGR—Immune System—IFNG—leprosy	1.11e-05	0.000149	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—CD4—leprosy	1.11e-05	0.000149	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD8A—leprosy	1.11e-05	0.000149	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—CD4—leprosy	1.11e-05	0.000148	CbGpPWpGaD
Dasatinib—LCK—Immune System—NOD2—leprosy	1.11e-05	0.000148	CbGpPWpGaD
Dasatinib—HCK—Disease—CD4—leprosy	1.1e-05	0.000147	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-DRB1—leprosy	1.1e-05	0.000147	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-DRB1—leprosy	1.1e-05	0.000147	CbGpPWpGaD
Dasatinib—HCK—Immune System—IL2—leprosy	1.1e-05	0.000147	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—CD4—leprosy	1.09e-05	0.000147	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RIPK2—leprosy	1.09e-05	0.000146	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—CD4—leprosy	1.09e-05	0.000146	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD40LG—leprosy	1.08e-05	0.000145	CbGpPWpGaD
Dasatinib—SRC—Immune System—RIPK2—leprosy	1.08e-05	0.000145	CbGpPWpGaD
Dasatinib—BLK—Immune System—CD4—leprosy	1.08e-05	0.000145	CbGpPWpGaD
Dasatinib—SRC—Immune System—TLR2—leprosy	1.08e-05	0.000145	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—IL2—leprosy	1.08e-05	0.000144	CbGpPWpGaD
Dasatinib—FGR—Immune System—CD4—leprosy	1.08e-05	0.000144	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD8A—leprosy	1.07e-05	0.000143	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—CD4—leprosy	1.07e-05	0.000143	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD40LG—leprosy	1.07e-05	0.000143	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—IL2—leprosy	1.06e-05	0.000142	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD8A—leprosy	1.06e-05	0.000141	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—CD4—leprosy	1.05e-05	0.000141	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—CD4—leprosy	1.05e-05	0.000141	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-DRB1—leprosy	1.04e-05	0.000139	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—CD4—leprosy	1.04e-05	0.000139	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—IL2—leprosy	1.03e-05	0.000138	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IFNG—leprosy	1.02e-05	0.000137	CbGpPWpGaD
Dasatinib—BLK—Immune System—IL2—leprosy	9.93e-06	0.000133	CbGpPWpGaD
Dasatinib—FGR—Immune System—IL2—leprosy	9.9e-06	0.000133	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CD4—leprosy	9.89e-06	0.000133	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RIPK2—leprosy	9.82e-06	0.000132	CbGpPWpGaD
Dasatinib—SRC—Immune System—NOD2—leprosy	9.79e-06	0.000131	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RIPK2—leprosy	9.62e-06	0.000129	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RIPK2—leprosy	9.47e-06	0.000127	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-DRB1—leprosy	9.38e-06	0.000126	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD40LG—leprosy	9.35e-06	0.000125	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—IL2—leprosy	9.31e-06	0.000125	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD8A—leprosy	9.24e-06	0.000124	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL2—leprosy	9.23e-06	0.000124	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-DRB1—leprosy	9.18e-06	0.000123	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-DRB1—leprosy	9.14e-06	0.000122	CbGpPWpGaD
Dasatinib—ERBB3—Disease—CD4—leprosy	9.13e-06	0.000122	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RIPK2—leprosy	9.12e-06	0.000122	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—CD4—leprosy	9.11e-06	0.000122	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL2—leprosy	9.1e-06	0.000122	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-DRB1—leprosy	9.04e-06	0.000121	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SDHD—leprosy	9.01e-06	0.000121	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RIPK2—leprosy	9e-06	0.000121	CbGpPWpGaD
Dasatinib—YES1—Immune System—IFNG—leprosy	8.99e-06	0.00012	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL2—leprosy	8.94e-06	0.00012	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CD4—leprosy	8.75e-06	0.000117	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-DRB1—leprosy	8.7e-06	0.000117	CbGpPWpGaD
Dasatinib—YES1—Immune System—CD4—leprosy	8.68e-06	0.000116	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-DRB1—leprosy	8.59e-06	0.000115	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TNF—leprosy	8.44e-06	0.000113	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TNF—leprosy	8.4e-06	0.000112	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TNF—leprosy	8.31e-06	0.000111	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD40LG—leprosy	8.27e-06	0.000111	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—IL2—leprosy	8.25e-06	0.00011	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD8A—leprosy	8.18e-06	0.00011	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CD4—leprosy	8.07e-06	0.000108	CbGpPWpGaD
Dasatinib—KIT—Immune System—IFNG—leprosy	8.03e-06	0.000108	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—leprosy	8e-06	0.000107	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL2—leprosy	7.99e-06	0.000107	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—leprosy	7.9e-06	0.000106	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RIPK2—leprosy	7.88e-06	0.000106	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD4—leprosy	7.76e-06	0.000104	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD4—leprosy	7.75e-06	0.000104	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	7.75e-06	0.000104	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IFNG—leprosy	7.6e-06	0.000102	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-DRB1—leprosy	7.53e-06	0.000101	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD4—leprosy	7.34e-06	9.83e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SDHD—leprosy	7.2e-06	9.64e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—CD4—leprosy	7.16e-06	9.59e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL2—leprosy	7.14e-06	9.56e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RIPK2—leprosy	6.98e-06	9.35e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IFNG—leprosy	6.85e-06	9.17e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CD4—leprosy	6.78e-06	9.08e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL2—leprosy	6.76e-06	9.05e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—IL2—leprosy	6.72e-06	9e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IFNG—leprosy	6.71e-06	8.98e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL2—leprosy	6.68e-06	8.94e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IFNG—leprosy	6.67e-06	8.94e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-DRB1—leprosy	6.66e-06	8.92e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD4—leprosy	6.61e-06	8.86e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IFNG—leprosy	6.6e-06	8.84e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD4—leprosy	6.48e-06	8.67e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD4—leprosy	6.45e-06	8.63e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD4—leprosy	6.38e-06	8.54e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IFNG—leprosy	6.36e-06	8.51e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IFNG—leprosy	6.27e-06	8.4e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD4—leprosy	6.14e-06	8.22e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—leprosy	6.12e-06	8.2e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CD4—leprosy	6.11e-06	8.18e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL2—leprosy	6.11e-06	8.18e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL2—leprosy	6.1e-06	8.17e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL2—leprosy	6.09e-06	8.15e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD4—leprosy	6.06e-06	8.12e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL2—leprosy	5.96e-06	7.98e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL2—leprosy	5.93e-06	7.94e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CD4—leprosy	5.89e-06	7.88e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL2—leprosy	5.89e-06	7.88e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL2—leprosy	5.87e-06	7.86e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL2—leprosy	5.65e-06	7.57e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD4—leprosy	5.6e-06	7.49e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL2—leprosy	5.58e-06	7.47e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SDHD—leprosy	5.55e-06	7.44e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IFNG—leprosy	5.5e-06	7.36e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—leprosy	5.31e-06	7.11e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—leprosy	5.17e-06	6.92e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—leprosy	4.9e-06	6.56e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—leprosy	4.88e-06	6.54e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—leprosy	4.87e-06	6.52e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—leprosy	4.7e-06	6.29e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—leprosy	4.61e-06	6.18e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—leprosy	4.37e-06	5.85e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—leprosy	4.34e-06	5.81e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—leprosy	4.32e-06	5.79e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—leprosy	3.93e-06	5.27e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—leprosy	3.85e-06	5.16e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—leprosy	3.79e-06	5.08e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—leprosy	3.65e-06	4.89e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—leprosy	3.61e-06	4.83e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—leprosy	3.16e-06	4.23e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—leprosy	2.8e-06	3.74e-05	CbGpPWpGaD
